Potential Spire Healthcare Group transaction

News

DateTitle 
28/06/2018Mediclinic Intnl plc - 2018 Capital Markets Day
RNS Number : 8157S Mediclinic International plc 28 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   28 June 2018   2018 Capital Markets Day   Mediclinic International plc, the international private healthcare services group, will today host a Capita... 
Printer Friendly Version
27/06/2018Mediclinic Intnl plc - South African B-BBEE Act: Annual Compliance Report
RNS Number : 6666S Mediclinic International plc 27 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   27 June 2018   BROAD-BASED BLACK ECONOMIC EMPOWERMENT ACT: ANNUAL COMPLIANCE REPORT   In accordance with the JSE Listings Requirements, applicable to the Company ... 
Printer Friendly Version
22/06/2018Mediclinic Intnl plc - Annual Financial Report
RNS Number : 2038S Mediclinic International plc 22 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   22 June 2018   POSTING OF ANNUAL REPORT AND FINANCIAL STATEMENTS, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM   Mediclinic announces t... 
Printer Friendly Version
21/06/2018Mediclinic Intnl plc - Tax Treatment for South African Dividends
RNS Number : 1759S Mediclinic International plc 21 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South African income tax number: 9950122714 ("Mediclinic", the "Company" or the "Group")   21 June 2018   TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE SOUTH AFRICAN REGISTER   Bac... 
Printer Friendly Version
18/06/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 6908R Mediclinic International plc 18 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   18 June 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   Awards gr... 
Printer Friendly Version
05/06/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3469Q Mediclinic International plc 05 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   5 June 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   Vesting of... 
Printer Friendly Version
01/06/2018Mediclinic Intnl plc - Director Declaration
RNS Number : 8525P Mediclinic International plc 01 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   1 June 2018   DIRECTOR DECLARATION   Mediclinic, a leading international private healthcare services group, confirms that, as announced on 29 March 2018, Dr Ronni... 
Printer Friendly Version
30/05/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 7232P Mediclinic International plc 30 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   30 May 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   On 24 and 2... 
Printer Friendly Version
24/05/2018Mediclinic Intnl plc - Final Results
RNS Number : 0970P Mediclinic International plc 24 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI                                                ... 
Printer Friendly Version
24/05/2018Mediclinic Intnl plc - Directorate Change
RNS Number : 1022P Mediclinic International plc 24 May 2018         Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   24 May 2018   Chief Executive Officer to continue as a Non-executive Director   Mediclinic, a leading international private ... 
Printer Friendly Version
15/05/2018Mediclinic Intnl plc - Appointment of Joint Corporate Broker
RNS Number : 0316O Mediclinic International plc 15 May 2018       Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   15 May 2018   Appointment of Joint Corporate Broker   Mediclinic International plc, the international private healthcare services grou... 
Printer Friendly Version
08/05/2018Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 3450N Mediclinic International plc 08 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60     8 May 2018   Notification of Major Interest in Mediclinic International plc shares   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are atta... 
Printer Friendly Version
27/04/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 4649M Mediclinic International plc 27 April 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   27 April 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   On 8 an... 
Printer Friendly Version
18/04/2018Mediclinic Intnl plc - 2018 Full Year Trading Update
RNS Number : 2412L Mediclinic International plc 18 April 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.   18 April 2018   2018 Full Year Trading Update   Mediclinic International plc, the internatio... 
Printer Friendly Version
06/04/2018Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 1103K Mediclinic International plc 06 April 2018    Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60     6 April 2018     Notification of Major Interest in Mediclinic International plc shares   1a. Identity of the issuer or the underlying issuer of existing shar... 
Printer Friendly Version
29/03/2018Mediclinic Intnl plc - Directorate Change
RNS Number : 3188J Mediclinic International plc 29 March 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   29 March 2018   Chief Executive Officer succession and other changes to the composition of the Board and its Committees   Mediclinic, a leading... 
Printer Friendly Version
13/12/2017Mediclinic Intnl plc - Tax Treatment for South African Dividends
RNS Number : 2671Z Mediclinic International plc 13 December 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South African income tax number: 9950122714 ("Mediclinic" or the "Company")   13 December 2017   TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE SOUTH AFRICAN REGISTER   Backgroun... 
Printer Friendly Version
04/12/2017Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3188Y Mediclinic International plc 04 December 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or the "Company")     4 December 2017   Purchase of shares in Mediclinic by Dr Carel Aron van der Merwe   On 1 December 2017, Dr Carel Aron van der Merwe acquired 10,000 shares ... 
Printer Friendly Version
28/11/2017Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 7661X Mediclinic International plc 28 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   28 November 2017   Notification of Major Interest in Mediclinic International plc shares     1a. Identity of the issuer or the un... 
Printer Friendly Version
27/11/2017Mediclinic Intnl plc - Directorate Change
RNS Number : 6211X Mediclinic International plc 27 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION     27 November 2017       APPOINTMENT OF GROUP CHIEF EXECUTIVE OFFICER     Medic... 
Printer Friendly Version
23/11/2017Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3900X Mediclinic International plc 23 November 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or the "Company")     23 November 2017   Purchase of shares in Mediclinic by Jurgens Myburgh, Chief Financial Officer   On 21 November 2017, Jurgens Myburgh, Chief Finan... 
Printer Friendly Version
20/11/2017Mediclinic Intnl plc - Rule 2.8 Announcement
RNS Number : 9096W Mediclinic International plc 20 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic")   FOR IMMEDIATE RELEASE   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.   THI... 
Printer Friendly Version
16/11/2017Mediclinic Intnl plc - Announcement Regarding Spire Healthcare Group plc
RNS Number : 6299W Mediclinic International plc 16 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic")   FOR IMMEDIATE RELEASE   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.   THI... 
Printer Friendly Version
08/11/2017Mediclinic Intnl plc - Amended Form 8 (OPD) Mediclinic International plc
RNS Number : 9583V Mediclinic International plc 08 November 2017   FORM 8 (OPD)   Amendment: replacement of RNS 6613V to reflect changes to section 3(d) below   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Mediclinic International plc ("Mediclinic") (b) Owner or controller ... 
Printer Friendly Version
06/11/2017Mediclinic Intnl plc - Form 8 (OPD) - Mediclinic International plc
RNS Number : 6613V Mediclinic International plc 06 November 2017    FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Mediclinic International plc ("Mediclinic") (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  &... 
Printer Friendly Version
06/11/2017Mediclinic Intnl plc - Form 8 (OPD) - Spire Healthcare Group plc
RNS Number : 6622V Mediclinic International plc 06 November 2017   FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Mediclinic International plc ("Mediclinic") (b) Owner or controller of interests and short positions disclosed, if different from 1(a):    ... 
Printer Friendly Version
24/10/2017Mediclinic Intnl plc - Notice in terms of Rule 22 of Takeover Code
... 
Printer Friendly Version
23/10/2017Mediclinic Intnl plc - Statement re Possible Offer
Mediclinic International plc23 October 2017  Mediclinic International plc(Incorporated in England and Wales)Company Number: 08338604LSE Share Code: MDCJSE Share Code: MEINSX Share Code: MEPISIN: GB00B8HX8Z88LEI: 2138002S5BSBIZTD5I60("Mediclinic") FOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTI... 
Printer Friendly Version

Rule 8 Disclosures

DateTitle 
28/06/2018Mediclinic Intnl plc - 2018 Capital Markets Day
RNS Number : 8157S Mediclinic International plc 28 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   28 June 2018   2018 Capital Markets Day   Mediclinic International plc, the international private healthcare services group, will today host a Capita... 
Printer Friendly Version
27/06/2018Mediclinic Intnl plc - South African B-BBEE Act: Annual Compliance Report
RNS Number : 6666S Mediclinic International plc 27 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   27 June 2018   BROAD-BASED BLACK ECONOMIC EMPOWERMENT ACT: ANNUAL COMPLIANCE REPORT   In accordance with the JSE Listings Requirements, applicable to the Company ... 
Printer Friendly Version
22/06/2018Mediclinic Intnl plc - Annual Financial Report
RNS Number : 2038S Mediclinic International plc 22 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   22 June 2018   POSTING OF ANNUAL REPORT AND FINANCIAL STATEMENTS, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM   Mediclinic announces t... 
Printer Friendly Version
21/06/2018Mediclinic Intnl plc - Tax Treatment for South African Dividends
RNS Number : 1759S Mediclinic International plc 21 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South African income tax number: 9950122714 ("Mediclinic", the "Company" or the "Group")   21 June 2018   TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE SOUTH AFRICAN REGISTER   Bac... 
Printer Friendly Version
18/06/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 6908R Mediclinic International plc 18 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   18 June 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   Awards gr... 
Printer Friendly Version
05/06/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3469Q Mediclinic International plc 05 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   5 June 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   Vesting of... 
Printer Friendly Version
01/06/2018Mediclinic Intnl plc - Director Declaration
RNS Number : 8525P Mediclinic International plc 01 June 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   1 June 2018   DIRECTOR DECLARATION   Mediclinic, a leading international private healthcare services group, confirms that, as announced on 29 March 2018, Dr Ronni... 
Printer Friendly Version
30/05/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 7232P Mediclinic International plc 30 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   30 May 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   On 24 and 2... 
Printer Friendly Version
24/05/2018Mediclinic Intnl plc - Final Results
RNS Number : 0970P Mediclinic International plc 24 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI                                                ... 
Printer Friendly Version
24/05/2018Mediclinic Intnl plc - Directorate Change
RNS Number : 1022P Mediclinic International plc 24 May 2018         Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   24 May 2018   Chief Executive Officer to continue as a Non-executive Director   Mediclinic, a leading international private ... 
Printer Friendly Version
15/05/2018Mediclinic Intnl plc - Appointment of Joint Corporate Broker
RNS Number : 0316O Mediclinic International plc 15 May 2018       Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   15 May 2018   Appointment of Joint Corporate Broker   Mediclinic International plc, the international private healthcare services grou... 
Printer Friendly Version
08/05/2018Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 3450N Mediclinic International plc 08 May 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60     8 May 2018   Notification of Major Interest in Mediclinic International plc shares   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are atta... 
Printer Friendly Version
27/04/2018Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 4649M Mediclinic International plc 27 April 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   27 April 2018   NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   On 8 an... 
Printer Friendly Version
18/04/2018Mediclinic Intnl plc - 2018 Full Year Trading Update
RNS Number : 2412L Mediclinic International plc 18 April 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.   18 April 2018   2018 Full Year Trading Update   Mediclinic International plc, the internatio... 
Printer Friendly Version
06/04/2018Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 1103K Mediclinic International plc 06 April 2018    Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60     6 April 2018     Notification of Major Interest in Mediclinic International plc shares   1a. Identity of the issuer or the underlying issuer of existing shar... 
Printer Friendly Version
29/03/2018Mediclinic Intnl plc - Directorate Change
RNS Number : 3188J Mediclinic International plc 29 March 2018   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   29 March 2018   Chief Executive Officer succession and other changes to the composition of the Board and its Committees   Mediclinic, a leading... 
Printer Friendly Version
13/12/2017Mediclinic Intnl plc - Tax Treatment for South African Dividends
RNS Number : 2671Z Mediclinic International plc 13 December 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South African income tax number: 9950122714 ("Mediclinic" or the "Company")   13 December 2017   TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE SOUTH AFRICAN REGISTER   Backgroun... 
Printer Friendly Version
04/12/2017Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3188Y Mediclinic International plc 04 December 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or the "Company")     4 December 2017   Purchase of shares in Mediclinic by Dr Carel Aron van der Merwe   On 1 December 2017, Dr Carel Aron van der Merwe acquired 10,000 shares ... 
Printer Friendly Version
28/11/2017Mediclinic Intnl plc - Holding(s) in Company
RNS Number : 7661X Mediclinic International plc 28 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group")   28 November 2017   Notification of Major Interest in Mediclinic International plc shares     1a. Identity of the issuer or the un... 
Printer Friendly Version
27/11/2017Mediclinic Intnl plc - Directorate Change
RNS Number : 6211X Mediclinic International plc 27 November 2017   Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or "the Company")   THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION     27 November 2017       APPOINTMENT OF GROUP CHIEF EXECUTIVE OFFICER     Medic... 
Printer Friendly Version
23/11/2017Mediclinic Intnl plc - Director/PDMR Shareholding
RNS Number : 3900X Mediclinic International plc 23 November 2017   Mediclinic International PLC (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic" or the "Company")     23 November 2017   Purchase of shares in Mediclinic by Jurgens Myburgh, Chief Financial Officer   On 21 November 2017, Jurgens Myburgh, Chief Finan... 
Printer Friendly Version
31/10/2017Form 8.3 - Spire Healthcare Group plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicl... 
Printer Friendly Version
31/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or ... 
Printer Friendly Version
31/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Nomura International PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a... 
Printer Friendly Version
31/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser:   Carlson Capital, L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For ... 
Printer Friendly Version
31/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.&n... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")  1.         KEY INFORMATION (a) Full name of discloser:BlackRock, Inc.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Old Mutual plc(and subsidiaries)(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient. ... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Marshall Wace LLP (on behalf of itself and its affiliates)(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle compa... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehi... 
Printer Friendly Version
30/10/2017Invesco Ltd. : Form 8.3 - Amendment to Form 8.3 Mediclinic International Plc 24102017
   Invesco Ltd. : Form 8.3 - Amendment to Form 8.3 Mediclinic International Plc 24102017 Amendment to Opening Position DisclosureFORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION(a) Full name of discloser:   Invesco Ltd. (b) Owner or controller of interests and short ... 
Printer Friendly Version
30/10/2017Invesco Ltd. : Form 8.3 - Mediclinic International Plc
   Invesco Ltd. : Form 8.3 - Mediclinic International Plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION(a) Full name of discloser:   Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     ... 
Printer Friendly Version
30/10/2017Form 8.3 - MEDICLINIC INTERNATIONAL PLC
   Form 8.3 - MEDICLINIC INTERNATIONAL PLC LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a)   Full name of discloser:   Barclays PLC.   ... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Genesis Asset Managers, LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For... 
Printer Friendly Version
30/10/2017Dimensional Fund Advisors Ltd. : Form 8.3 - Mediclinic International Plc - Ordinary Shares
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION(a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim benefic... 
Printer Friendly Version
30/10/2017Form 8.3 - Mediclinic International Plc
RNS Number : 9463UCoronation Asset Management Pty Ltd30 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):  ... 
Printer Friendly Version
27/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")  1.         KEY INFORMATION (a) Full name of discloser:BlackRock, Inc.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
27/10/2017Form 8.3 - Mediclinic International PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Marshall Wace LLP (on behalf of itself and its affiliates)(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle compa... 
Printer Friendly Version
27/10/2017Form 8.3 - Spire Healthcare Group Plc
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
27/10/2017Form 8.3 - MEDICLINIC INTERNATIONAL PLC
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a)   Full name of discloser:   Barclays PLC.       (b) Owner or controller of intere... 
Printer Friendly Version
27/10/2017Form 8.3 - MEDICLINIC INTERNATIONAL PLC
Form 8.3 - MEDICLINIC INTERNATIONAL PLC -... 
Printer Friendly Version
27/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.&n... 
Printer Friendly Version
26/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")  1.         KEY INFORMATION (a) Full name of discloser:BlackRock, Inc.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
26/10/2017Form 8.3 - Spire Healthcare Group Plc
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
26/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Old Mutual plc(and subsidiaries)(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient. ... 
Printer Friendly Version
26/10/2017Form 8.3 - Mediclinic International
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Genesis Asset Managers, LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For... 
Printer Friendly Version
26/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Standard Life Aberdeen plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For ... 
Printer Friendly Version
26/10/2017Form 8.3 - MEDICLINIC INTERNATIONAL PLC
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a)   Full name of discloser:   Barclays PLC.       (b) Owner or controller of intere... 
Printer Friendly Version
26/10/2017Form 8.3 - [Mediclinic International Plc]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.&n... 
Printer Friendly Version
26/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Nomura International PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a... 
Printer Friendly Version
25/10/2017Form 8.3 - Amendment Mediclinic International Plc
 AMENDMENT to Section 2(a) - Replaces 6086U and 6114U  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):  &nbs... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")  1.         KEY INFORMATION (a) Full name of discloser:BlackRock, Inc.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or ... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Coronation Asset Management Pty Ltd(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.&n... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International plc
   Form 8.3 - Mediclinic International plc LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a)   Full name of discloser:   Barclays PLC.   ... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Nomura International PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a... 
Printer Friendly Version
25/10/2017Form 8.3 - Mediclinic International
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Genesis Asset Managers, LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International PLC - 24 Oct 2017 17:00
   Form 8.3 - Mediclinic International PLC DENVER--(BUSINESS WIRE)--FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser:   OppenheimerFunds, Inc. (b) Owner or controller of interests and short positions disclosed, if different fr... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Standard Life Aberdeen plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For ... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:Nomura International PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")  1.         KEY INFORMATION (a) Full name of discloser:BlackRock, Inc.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International Plc
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a tru... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International plc
   Form 8.3 - Mediclinic International plc LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a)   Full name of discloser:   Barclays PLC.   ... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International Plc
 PUBLIC OPENING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") AMENDMENT to 3652U - see asterisks in 2(a) 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle co... 
Printer Friendly Version
24/10/2017Form 8.3 - Mediclinic International PLC
   Form 8.3 - Mediclinic International PLC FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION(a) Full name of discloser:Norges Bank(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is ins... 
Printer Friendly Version
24/10/2017Form 8.3 - Medicinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:GIC Private Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a trust... 
Printer Friendly Version
23/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or ... 
Printer Friendly Version
23/10/2017Form 8.3 - Spire Healthcare Group plc
 PUBLIC OPENING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Legal And General Investment Management Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a trust, the ... 
Printer Friendly Version
23/10/2017Form 8.3 - Spire Healthcare Group plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicl... 
Printer Friendly Version
23/10/2017Form 8.3 - Mediclinic International plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:State Street Global Advisors & Affiliates (b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or ... 
Printer Friendly Version
23/10/2017Dimensional Fund Advisors Ltd. : Form 8.3 - Mediclinic International Plc - Ordinary Shares -
   Dimensional Fund Advisors Ltd. : Form 8.3 - Mediclinic International Plc - Ordinary Shares FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION(a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity as investment manager and on b... 
Printer Friendly Version